A detailed history of Verition Fund Management LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 1,054 shares of REGN stock, worth $795,632. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,054
Previous 8,553 87.68%
Holding current value
$795,632
Previous $8.99 Million 87.67%
% of portfolio
0.01%
Previous 0.05%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1024.09 - $1201.76 $7.68 Million - $9.01 Million
-7,499 Reduced 87.68%
1,054 $1.11 Million
Q2 2024

Aug 14, 2024

SELL
$883.2 - $1071.19 $4.13 Million - $5.01 Million
-4,679 Reduced 35.36%
8,553 $8.99 Million
Q1 2024

May 14, 2024

BUY
$902.69 - $993.35 $7.63 Million - $8.39 Million
8,451 Added 176.76%
13,232 $12.7 Million
Q4 2023

Feb 14, 2024

BUY
$775.18 - $881.7 $3.71 Million - $4.22 Million
4,781 New
4,781 $4.2 Million
Q2 2023

Aug 14, 2023

BUY
$700.03 - $830.35 $23,801 - $28,231
34 Added 4.65%
765 $549,000
Q1 2023

May 15, 2023

SELL
$680.49 - $826.97 $8.81 Million - $10.7 Million
-12,941 Reduced 94.65%
731 $600,000
Q4 2022

Feb 14, 2023

BUY
$705.89 - $766.39 $9.17 Million - $9.95 Million
12,986 Added 1893.0%
13,672 $9.86 Million
Q3 2022

Nov 14, 2022

SELL
$573.97 - $724.32 $685,320 - $864,838
-1,194 Reduced 63.51%
686 $473,000
Q2 2022

Aug 15, 2022

BUY
$548.35 - $738.84 $724,918 - $976,746
1,322 Added 236.92%
1,880 $1.11 Million
Q1 2022

May 13, 2022

SELL
$595.12 - $698.43 $276,730 - $324,769
-465 Reduced 45.45%
558 $390,000
Q4 2021

May 03, 2022

SELL
$543.48 - $670.97 $4.24 Million - $5.23 Million
-7,800 Reduced 88.41%
1,023 $646,000
Q4 2021

Feb 14, 2022

BUY
$543.48 - $670.97 $3.99 Million - $4.93 Million
7,341 Added 495.34%
8,823 $5.57 Million
Q3 2021

Nov 15, 2021

SELL
$574.03 - $680.96 $447,169 - $530,467
-779 Reduced 34.45%
1,482 $897,000
Q2 2021

Aug 16, 2021

BUY
$472.8 - $558.54 $1.07 Million - $1.26 Million
2,261 New
2,261 $1.26 Million
Q4 2020

Feb 16, 2021

SELL
$478.3 - $607.98 $361,116 - $459,024
-755 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$544.75 - $658.21 $78,444 - $94,782
-144 Reduced 16.02%
755 $423,000
Q2 2020

Aug 14, 2020

BUY
$493.32 - $643.92 $443,494 - $578,884
899 New
899 $561,000
Q1 2020

May 15, 2020

SELL
$336.18 - $494.43 $1.19 Million - $1.74 Million
-3,528 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$274.13 - $376.51 $2.58 Million - $3.54 Million
-9,403 Reduced 72.72%
3,528 $1.33 Million
Q3 2019

Nov 14, 2019

BUY
$273.46 - $318.39 $666,422 - $775,916
2,437 Added 23.22%
12,931 $3.59 Million
Q2 2019

Aug 14, 2019

BUY
$299.6 - $414.82 $2.85 Million - $3.95 Million
9,519 Added 976.31%
10,494 $3.29 Million
Q1 2019

May 15, 2019

BUY
$372.08 - $439.57 $362,778 - $428,580
975 New
975 $400,000
Q4 2018

Feb 14, 2019

SELL
$335.82 - $403.04 $1.24 Million - $1.48 Million
-3,682 Closed
0 $0
Q3 2018

Nov 15, 2018

BUY
$351.14 - $408.51 $1.29 Million - $1.5 Million
3,682 New
3,682 $1.49 Million
Q1 2018

May 16, 2018

SELL
$315.82 - $393.78 $579,529 - $722,586
-1,835 Closed
0 $0
Q4 2017

Feb 15, 2018

SELL
$358.63 - $469.95 $31,559 - $41,355
-88 Reduced 4.58%
1,835 $690,000
Q3 2017

Nov 14, 2017

BUY
$431.38 - $504.0 $829,543 - $969,192
1,923
1,923 $860,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $80.9B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.